首页> 外文OA文献 >Role of Metformin in Combination with Trastuzumab and Neoadjuvant Chemotherapy in Treatment of HER-2 Positive Breast Cancer

【2h】

Role of Metformin in Combination with Trastuzumab and Neoadjuvant Chemotherapy in Treatment of HER-2 Positive Breast Cancer

机译：二甲双胍与曲妥珠单抗和新辅助化疗组合治疗患者-2阳性乳腺癌的作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ahmed Said Ahmed Said; Hussein Ali Mustafa Abd Al-Mutteleb; Mohammed Ali Morsy Abdeen; Mohammed Abd Al Rahman Hassan; Soha Abdelrazek Abbas Ahmed;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort. [J] . Gianni L, Eiermann W, Semiglazov V, The Lancet . 2010,第9712期

机译：对于HER2阳性的局部晚期乳腺癌患者，使用曲妥珠单抗的新辅助化疗联合曲妥珠单抗辅助与单独的新辅助化疗相比（NOAH试验）：一项平行HER2阴性队列的随机对照优势试验。
2. TBCRC049: A phase II non-randomized study to assess the safety and efficacy of the combination of tucatinib and trastuzumab and capecitabine for treatment of leptomeningeal metastases in HER2 positive breast cancer TBCRC049: A phase II non-randomized study to assess the safety and efficacy of the combination of tucatinib and trastuzumab and capecitabine for treatment of leptomeningeal metastases in HER2 positive breast cancer [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：TBCRC049：II期非随机性研究，以评估Tucatinib和Trastuzumab和Capecitabine的组合的安全性和功效，用于治疗Her2阳性乳腺癌TBCRC049中的百分声膜转移：II期非随机性研究，以评估安全性和疗效 Tucatinib和Trastuzumab和Capecitabine的组合治疗HER2阳性乳腺癌中的百分症转移
3. Dual Block with Lapatinib and Trastuzumab Versus Single-Agent Trastuzumab Combined with Chemotherapy as Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Meta-analysis of Randomized Trials [J] . Clavarezza Matteo, Puntoni Matteo, Gennari Alessandra, Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第18期

机译：拉帕替尼和曲妥珠单抗与单药曲妥珠单抗联合化疗联合化疗作为HER2阳性乳腺癌新辅助治疗的随机对照试验的荟萃分析
4. Breast MRI radiomics for the pre-treatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients [C] . Karen Drukker, Iman El-Bawab, Alexandra Edwards, SPIE Conference on Computer-Aided Diagnosis . 2019

机译：乳腺MRI辐射射清，用于节点阳性乳腺癌患者对新辅助化疗的反应预处理预测
5. Impact of HER-2/neu detection by fluorescence in situ hybridization (FISH) on trastuzumab therapy in the treatment of metastatic breast cancer. [D] . Subongkot, Suphat. 2003

机译：荧光原位杂交（FISH）检测HER-2 / neu对曲妥珠单抗治疗转移性乳腺癌的影响。
6. A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study [O] . Begoña Martin-Castillo, Sonia Pernas, Joan Dorca, 2018

机译：新辅助二甲双胍联合曲妥珠单抗联合化学疗法治疗早期HER2阳性乳腺癌女性的2期试验：METTEN研究
7. Role of Metformin in Combination with Neoadjuvant Chemotherapy in Treatment of Breast Cancer [O] . Ahmed Said Ahmed Said, Hussein Ali Mustafa abd Al-Mutteleb, Mohammed Ali Morsy Abdeen, 2020

机译：二甲双胍与Neoadjuvant化疗组合治疗乳腺癌的作用

Role of Metformin in Combination with Trastuzumab and Neoadjuvant Chemotherapy in Treatment of HER-2 Positive Breast Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅